ArticleHemaSphere2026

Autologous stem cell transplantation versus consolidation chemotherapy as postremission treatment in newly diagnosed favorable- and intermediate-risk patients with AML: A comparative analysis of HOVON-SAKK-Nordic trials.

Dimitrios Kotsos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.